Available to sourceHuman Prescription DrugGastrointestinal

Sodium Chloride

4 meq/mL · Injection Solution Concentrate

By Fresenius Kabi USA, LLC

NDC: 63323-095
Route: Intravenous
Therapeutic class: Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative
Marketing category: ANDA

Package sizes

20 VIAL, PLASTIC in 1 TRAY (63323-095-61) / 100 mL in 1 VIAL, PLASTIC (63323-095-02)NDC 63323-095-61Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.